Evidence that a nigral gabaergic--cholinergic balance controls posture

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• The substantia nigra (SN) plays a crucial role in motor control.
• Muscarinic and GABAergic receptors within the SN are implicated in movement regulation.
• Understanding their interplay is vital for addressing movement disorders.

Purpose of the Study:

• To investigate the functional roles of muscarinic and GABA receptors in the substantia nigra pars reticulata.
• To elucidate the involvement of these receptors in motor control and parkinsonian syndromes.

Main Methods:

• Intranigral injections of kainic acid to create lesions.
• Administration of carbachol, scopolamine, picrotoxin, apomorphine, and muscimol into the substantia nigra.
• Assessment of behavioral responses including turning, catalepsy, tremors, and rigidity.

Main Results:

• Kainic acid lesions reduced muscarinic receptor binding and choline acetyltransferase (CAT) activity in the pars reticulata.
• Intranigral carbachol induced dose-related turning and rigid catalepsy, antagonized by scopolamine.
• Intranigral scopolamine antagonized haloperidol-induced catalepsy and prevented arecoline-induced parkinsonian symptoms, while muscimol blocked arecoline-induced parkinsonism.

Conclusions:

• Muscarinic receptors in the substantia nigra pars reticulata are involved in posture control.
• These muscarinic receptors exert an influence opposite to that of nigral GABA receptors.
• Targeting nigral muscarinic receptors may offer therapeutic potential for movement disorders.